Oral Presentations

O_02

R.J. Molinaro, et al.

A novel gene product of the prostate cancer associated retrovirus, XMRV.

O_03

Therapeutics/

Vaccine

(animal models)

Y. Ikeda, et al.

Wild-derived mouse (Mus pahari) as a small animal model for XMRV infection.

O_04

F. Villinger, et al.

XMRV induces a chronic replicative infection in rhesus macaques tissues but not in blood.

klik hier

O_05

Host restriction factors

C. Kozak, et al.

Evolution and species distribution of functional and sequence variants of the mammalian XPR1 receptor for XMRV and mouse xenotropic gammaretroviruses.

O_06

Prostate cancer

J.A. Petros, et al.

Variant XMRVs in clinical prostate cancer.

O_07

K.S. Sfanos, et al.

Failure to detect XMRV in prostate cancer and benign prostatic tissues.

klik hier

O_08

N. Fischer, et al.

XMRV prevalence in prostate cancer tissue and the role of the prostate compartment in XMRV infection.

O_09

B.P. Danielson, et al.

XMRV infection of prostate cancer patients from the Southern United States and analysis of possible correlates of infection.

klik hier

O_10

B.T. Huber, et al.

Prevalence of XMRV in CFS patients and healthy controls.

O_11

M.R. Hanson, et al.

XMRV in Chronic Fatigue Syndrome: A Pilot Study.

O_13

J. Mikovits, et al.

Detection of infectious XMRV in the peripheral blood of chronic fatigue syndrome patients in the United Kingdom.

O_14

Assay development & Screening

R. Bagni, et al.

Development and optimization of a multiplex serological assay to detect XMRV antibodies.

klik hier

O_15

K. Lee, et al.

Development of a GFP-indicator cell line for the detection of XMRV.

O_16

X. Qiu, et al.

Development of XMRV immunoassays useful for epidemiologic studies.

klik hier

O_17

M. Kearney, et al.

Validation of XMRV single-copy assays (X-SCA) to detect xenotropic MLV-related virus in human blood products.

klik hier

O_18

O. Hohn, et al.

No evidence for XMRV in CFS and MS patients in Germany despite the ability of the virus to infect human blood cells in vitro.

O_19

J. Blomberg, et al.

Search for XMRV in Swedish patients with myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and prostate cancer; methods and results.

klik hier

O_20

G. Simmons, et al.

Multi-laboratory evaluations of XMRV nucleic acid detection assays.

klik hier

Poster Presentations

P_01

Basic virology

M. Eiden, et al.

Assessing the potential for XMRV endogenization.

P_02

S. Liu, et al.

Understanding the entry of XMRV.

P_03

S.M.R. Jensen, et al.

XMRV productively infects primary antigen-presenting cells.

P_04

Pathogenesis

M.C. Lee, et al.

XMRV infection induces host genes that regulate inflammation and cellular physiology.

P_05

J. Blanco, et al.

Detection of XMRV sequences in EBV-transformed B cell lines.

P_06

K. Devadas, et al.

Host factor involvement in XMRV infection-analysis of gene expression profiling using PCR array.

P_07

C. Cabrera, et al.

Xenotropic murine leukemia virus-related infection of human lymphoid tissue ex vivo.

P_08

K. Devadas, et al.

Host Factor involvement in XMRV infection-Analysis of Gene expression profile using Agilent microarray.

P_09

Therapeutics/ Vaccine (animal models)

M. Snyderman, et al.

XMRV: virological, immunological and clinical correlations in patients with Chronic Lymphocytic Leukemia and Mantle cell lymphoma (MCL).

klik hier

P_10

J. Cassella, et al.

Therapeutic targeting of TSG101 in XMRV-infected cells.

P_11

Prostate cancer

N. Makarova, et al.

Prevalence of neutralizing antibodies against XMRV in clinical prostate cancer.

P_12

Y. Ikeda, et al.

Prevalence of XMRV in prostate cancer patients at Mayo clinic.

P_13

Chronic Fatigue syndrome/neuro immune diseases

S.D. Vernon, et al.

Blood donation and transfusion in CFS patients.

P_14

D. Strayer, et al.

Comparison of demographic parameters and health/performance status of XMRV antibody positive vs. negative CFS subjects in a phase III clinical trial.

P_15

I. Silvestre, et al.

Mechanisms of induction of NK cell activity by ampligen® in XMRV-positive chronic fatigue syndrome patients.

P_16

P. Cheney.

XMRV detection in a national practice specializing in chronic fatigue syndrome (CFS).

P_17

V. Lombardi, et al.

Demographics of XMRV: a summary of national and international clinical laboratory testing.

P_18

M. Curriu, et al.

Altered B, T and NK cell phenotype in chronic fatigue syndrome (CFS) individuals.

P_19

M.A. Pfost, et al.

Detection of infectious XMRV in the peripheral blood of children.

P_20

K. de Meirleir, et al.

Is the mechanism of systemic immune activation in XMRV positive CFS patients similar to that observed in HIV?

klik hier

P_21

Assay development & Screening

J. Mikovits, et al.

Inactivation of XMRV in platelet and RBC components prepared with the intercept blood system.

P_22

J. Das Gupta, et al.

Presence of XMRV RNA in urine of prostate cancer patients.

P_23

S. Tang, et al.

Absence of detectable XMRV in plasma or PBMC of human immunodeficiency virus type one (HIV-1) infected individuals in Cameroon and Uganda.

Invited Lectures

L_01

Basic virology

J.M. Coffin.

Retroviruses: Endogenous MLV and XMRV.

klik hier

L_07

Host response

E. Sparger.

Vaccine development.

klik hier

L_08

K. Bishop.

Restriction of XMRV infection.

klik hier

L_12

Prostate Cancer

E.A. Klein.

XMRV and Prostate Cancer - A Clinician's View.

klik hier

L_13

I Singh.

XMRV: Pathogenesis.

klik hier

L_21

Chronic Fatigue syndrome/neuro immune diseases

S.C. Lo.

Detection of Murine Leukemia Virus (MLV)-related Virus Gene Sequences in Blood of Patients with Chronic Fatigue Syndrome and Blood Donors.

klik hier